Literature DB >> 6191854

Interstitial iodine-125 implant in the management of unresectable pancreatic carcinoma.

A M Syed, A A Puthawala, D L Neblett.   

Abstract

Eighteen patients with locally advanced adenocarcinoma of the head, body and tail of the pancreas were treated by a combination of biliary bypass, external and interstitial irradiation at Southern California Cancer Center of California Hospital Medical Center, Los Angeles, and Memorial Hospital Medical Center of Long Beach, Long Beach, CA, from July 31, 1975 to December 31, 1980. A dose of 3000 to 5000 rad was delivered to the pancreas and regional lymph nodes by external irradiation utilizing megavoltage units and 10,000 to 15,000 rad to the pancreas and metastatic lymph nodes by permanent Iodine-125 implants. In this group of 18 patients with unresectable carcinoma of the pancreas, excellent palliation of pain, jaundice and vomiting was achieved, with a median survival of 14 months.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191854     DOI: 10.1002/1097-0142(19830901)52:5<808::aid-cncr2820520510>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  The clinical utility of image-guided iodine-125 seed in patients with unresectable pancreatic cancer.

Authors:  Hongxin Niu; Xikun Zhang; Bin Wang; Zhao Zhou; Jian Wang; Zhongfa Xu
Journal:  Tumour Biol       Date:  2015-09-10

2.  Intraoperative electron beam therapy for unresectable cancer of the pancreas.

Authors:  R R Dobelbower; A elTaki; F Bagne; M I Ajlouni; A J Milligan; D G Bronn
Journal:  Int J Pancreatol       Date:  1989-02

Review 3.  Pancreatic cancer in 1988. Possibilities and probabilities.

Authors:  A L Warshaw; R S Swanson
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

4.  Treatment of pancreatic cancer by radiation therapy.

Authors:  R R Dobelbower; A J Milligan
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

5.  On the development of an interstitial radiation protocol for a multicenter consortium. Experience with permanent low-dose rate and temporary high-dose rate 125I implants in 'failed' and 'newly diagnosed' glioblastoma patients: quality assurance methodology and a possible future adjuvant for therapeutic enhancement.

Authors:  R G Selker; M S Eddy; M Deutsch; V C Arena; P Burger
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

6.  On a method of dosimetry planning and implantation of 125I for interstitial irradiation of malignant gliomas.

Authors:  M S Eddy; R G Selker; L L Anderson
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

7.  Pain management of patients with unresectable peripancreatic carcinoma.

Authors:  Rutger C I van Geenen; Claudia M G Keyzer-Dekker; Geertjan van Tienhoven; Huug Obertop; Dirk J Gouma
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

8.  Intraoperative radiotherapy for patients with carcinoma of the pancreas. The Howard University Hospital experience, 1978-1986.

Authors:  W B Tuckson; A L Goldson; E Ashayeri; M Halyard-Richardson; R L DeWitty; L D Leffall
Journal:  Ann Surg       Date:  1988-06       Impact factor: 12.969

9.  Intraoperative ultrasound-guided iodine-125 seed implantation for unresectable pancreatic carcinoma.

Authors:  Junjie Wang; Yuliang Jiang; Jinna Li; Suqing Tian; Weiqiang Ran; Dianrong Xiu
Journal:  J Exp Clin Cancer Res       Date:  2009-06-23

10.  The investigation of 125I seed implantation as a salvage modality for unresectable pancreatic carcinoma.

Authors:  Hao Wang; Junjie Wang; Yuliang Jiang; Jinna Li; Suqing Tian; Weiqiang Ran; Dianrong Xiu; Yang Gao
Journal:  J Exp Clin Cancer Res       Date:  2013-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.